Regenerative Bio

About Regenerative Bio

Regenerative Bio operates as an anti-aging biotechnology company, founded in 2021 by Xuechen Zhao, James Yang, Ringo Runzhou Ye, and Shenbo Fang, with its headquarters in Beijing, China. The company has secured $350K in funding from investors including IMO Ventures, Taihill Venture, and UpHonest Capital.

From a financial analyst's perspective, the company is positioned in the growing anti-aging sector, leveraging a technology-driven approach. It utilizes a combination of artificial intelligence, cloud computing, and quantum physics to research and identify anti-aging ingredients, formulas, and potential treatments. This strategy aims to address health issues associated with aging by focusing on improving energy metabolism and cellular health. The business model appears to be centered on the direct-to-consumer sale of dietary supplements, although it also enables healthcare professionals to use their findings.

Regenerative Bio has developed and offered products such as "NMN Prime 12000," an NAD+ precursor supplement, and "NMN Mate," a resveratrol-NMN booster. These products are designed to enhance energy metabolism and promote cellular health. The company's core strategy involves using its AI-powered platform for the discovery and formulation of these supplements. While one source indicates the company was founded in 2020 and is now deadpooled, other sources from 2021 onwards describe it as an active, privately held company with a team and recent funding, suggesting a possible pivot or restructuring.